Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 130

    1.

    Apixaban or Enoxaparin for Thromboprophylaxis.

    Gómez-Outes A, Suárez-Gea ML, Pozo-Hernández C, Lassen MR, Raskob GE, Gallus A.

    N Engl J Med. 2009 Nov 19;361(21):2100-2101. No abstract available. PMID: 19923583 [PubMed - as supplied by publisher]Related articles

    2.

    Pulmonary Arterial Hypertension: Baseline Characteristics From the REVEAL Registry.

    Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, Giles S, Feldkircher K, Miller DP, McGoon M.

    Chest. 2009 Oct 16. [Epub ahead of print]PMID: 19837821 [PubMed - as supplied by publisher]Related articles

    3.

    Apixaban or enoxaparin for thromboprophylaxis after knee replacement.

    Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Portman RJ.

    N Engl J Med. 2009 Aug 6;361(6):594-604. Erratum in: N Engl J Med. 2009 Oct 29;361(18):1814. PMID: 19657123 [PubMed - indexed for MEDLINE]Related articles

    4.

    Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome.

    Hull RD, Pineo GF, Brant R, Liang J, Cook R, Solymoss S, Poon MC, Raskob G; LITE Trial Investigators.

    Am J Med. 2009 Aug;122(8):762-769.e3.PMID: 19635277 [PubMed - indexed for MEDLINE]Related articles

    5.

    Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.

    van Doormaal FF, Raskob GE, Davidson BL, Decousus H, Gallus A, Lensing AW, Piovella F, Prins MH, Büller HR.

    Thromb Haemost. 2009 Apr;101(4):762-9.PMID: 19350123 [PubMed - indexed for MEDLINE]Related articles

    6.

    Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q).

    Prins MH, Guillemin I, Gilet H, Gabriel S, Essers B, Raskob G, Kahn SR.

    Health Qual Life Outcomes. 2009 Apr 7;7:30.PMID: 19348685 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Design of the REVEAL registry for US patients with pulmonary arterial hypertension.

    McGoon MD, Krichman A, Farber HW, Barst RJ, Raskob GE, Liou TG, Miller DP, Feldkircher K, Giles S.

    Mayo Clin Proc. 2008 Aug;83(8):923-31.PMID: 18674477 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

    Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ; American College of Chest Physicians.

    Chest. 2008 Jun;133(6 Suppl):454S-545S. Erratum in: Chest. 2008 Oct;134(4):892. PMID: 18574272 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.

    Buller HR, Lensing AW, Prins MH, Agnelli G, Cohen A, Gallus AS, Misselwitz F, Raskob G, Schellong S, Segers A; Einstein-DVT Dose-Ranging Study investigators.

    Blood. 2008 Sep 15;112(6):2242-7. Epub 2008 Jul 11.PMID: 18621928 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Challenges in the diagnosis of acute pulmonary embolism.

    Stein PD, Sostman HD, Bounameaux H, Buller HR, Chenevert TL, Dalen JE, Goodman LR, Gottschalk A, Hull RD, Leeper KV Jr, Pistolesi M, Raskob GE, Wells PS, Woodard PK.

    Am J Med. 2008 Jul;121(7):565-71. Review.PMID: 18589050 [PubMed - indexed for MEDLINE]Related articles

    11.

    Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.

    RE-MOBILIZE Writing Committee, Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Huo MH, Lieberman JR, Muntz JE, Raskob GE, Clements ML, Hantel S, Schnee JM, Caprini JA.

    J Arthroplasty. 2009 Jan;24(1):1-9. Epub 2008 Apr 14.PMID: 18534438 [PubMed - indexed for MEDLINE]Related articles

    12.

    Exclusion of first-episode deep-vein thrombosis after-hours using D-dimer.

    Rathbun SW, Whitsett TL, Raskob GE.

    Blood Coagul Fibrinolysis. 2007 Dec;18(8):795-800.PMID: 17982322 [PubMed - indexed for MEDLINE]Related articles

    13.

    American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

    Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H, Mendelson D, Raskob G, Somerfield MR, Thodiyil P, Trent D, Francis CW; American Society of Clinical Oncology.

    J Clin Oncol. 2007 Dec 1;25(34):5490-505. Epub 2007 Oct 29. Review.PMID: 17968019 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prevention of central venous catheter-associated thrombosis: a meta-analysis.

    Kirkpatrick A, Rathbun S, Whitsett T, Raskob G.

    Am J Med. 2007 Oct;120(10):901.e1-13. Review.PMID: 17904462 [PubMed - indexed for MEDLINE]Related articles

    15.

    Extended prophylaxis of venous thromboembolism with idraparinux.

    van Gogh Investigators, Buller HR, Cohen AT, Davidson B, Decousus H, Gallus AS, Gent M, Pillion G, Piovella F, Prins MH, Raskob GE.

    N Engl J Med. 2007 Sep 13;357(11):1105-12.PMID: 17855671 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Idraparinux versus standard therapy for venous thromboembolic disease.

    van Gogh Investigators, Buller HR, Cohen AT, Davidson B, Decousus H, Gallus AS, Gent M, Pillion G, Piovella F, Prins MH, Raskob GE.

    N Engl J Med. 2007 Sep 13;357(11):1094-104.PMID: 17855670 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.

    Davidson BL, Büller HR, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob GE, Segers AE, Lensing AW; Matisse Investigators.

    J Thromb Haemost. 2007 Jun;5(6):1191-4.PMID: 17403087 [PubMed - indexed for MEDLINE]Related articles

    18.

    Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms.

    Hull RD, Pineo GF, Brant RF, Mah AF, Burke N, Dear R, Wong T, Cook R, Solymoss S, Poon MC, Raskob G; LITE Trial Investigators.

    Am J Med. 2007 Jan;120(1):72-82.PMID: 17208082 [PubMed - indexed for MEDLINE]Related articles

    19.

    Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer.

    Hull RD, Pineo GF, Brant RF, Mah AF, Burke N, Dear R, Wong T, Cook R, Solymoss S, Poon MC, Raskob G; LITE Trial Investigators.

    Am J Med. 2006 Dec;119(12):1062-72.PMID: 17145251 [PubMed - indexed for MEDLINE]Related articles

    20.

    Duration of warfarin in pulmonary embolism.

    Miller A, Campbell I, Fennerty T, Raskob GE, Büller HR.

    Chest. 2006 Jul;130(1):299; author reply 299-300. No abstract available. PMID: 16840417 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Injury prevention and control research and training in accredited schools of public health: a CDC/ASPH assessment.

    Hemenway D, Aglipay GS, Helsing KL, Raskob GE.

    Public Health Rep. 2006 May-Jun;121(3):349-51. No abstract available. PMID: 16640161 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force.

    Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Lewis SZ, Schünemann H.

    Chest. 2006 Jan;129(1):174-81. Review.PMID: 16424429 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Chemical (VX) terrorist threat: public knowledge, attitudes, and responses.

    Henderson JN, Henderson LC, Raskob GE, Boatright DT.

    Biosecur Bioterror. 2004;2(3):224-8.PMID: 15588061 [PubMed - indexed for MEDLINE]Related articles

    24.

    Negative D-dimer result to exclude recurrent deep venous thrombosis: a management trial.

    Rathbun SW, Whitsett TL, Raskob GE.

    Ann Intern Med. 2004 Dec 7;141(11):839-45.PMID: 15583225 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

    Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE.

    Chest. 2004 Sep;126(3 Suppl):401S-428S. Review. Erratum in: Chest. 2005 Jan;127(1):416. PMID: 15383479 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

    Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S.

    Chest. 2004 Sep;126(3 Suppl):287S-310S. Review.PMID: 15383476 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery.

    Sullivan SD, Davidson BL, Kahn SR, Muntz JE, Oster G, Raskob G.

    Pharmacoeconomics. 2004;22(9):605-20.PMID: 15209529 [PubMed - indexed for MEDLINE]Related articles

    28.

    Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.

    Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, Segers AE, Cariou R, Leeuwenkamp O, Lensing AW; Matisse Investigators.

    Ann Intern Med. 2004 Jun 1;140(11):867-73.PMID: 15172900 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings.

    Rathbun SW, Whitsett TL, Vesely SK, Raskob GE.

    Chest. 2004 Mar;125(3):851-5.PMID: 15006941 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    The economics of venous thromboembolism prophylaxis: a primer for clinicians.

    Davidson BL, Sullivan SD, Kahn SR, Borris L, Bossuyt P, Raskob G.

    Chest. 2003 Dec;124(6 Suppl):393S-396S. Review.PMID: 14668423 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery.

    Raskob GE, Hirsh J.

    Chest. 2003 Dec;124(6 Suppl):379S-385S. Review.PMID: 14668421 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care.

    George JN, Raskob GE, Vesely SK, Moore D Jr, Lyons RM, Cobos E, Towell BL, Klug P, Guthrie TH.

    Am J Hematol. 2003 Nov;74(3):161-9.PMID: 14587042 [PubMed - indexed for MEDLINE]Related articles

    33.

    Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.

    Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, van den Berg-Segers AE, Cariou R, Leeuwenkamp O, Lensing AW; Matisse Investigators.

    N Engl J Med. 2003 Oct 30;349(18):1695-702. Erratum in: N Engl J Med. 2004 Jan 22;350(4):423. PMID: 14585937 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Helical computed tomography and magnet resonance imaging: diagnosis of pulmonary embolism in symptomatic patients.

    Blevins S, Edwards S, Raskob G.

    Curr Opin Hematol. 2003 Sep;10(5):345-50. Review.PMID: 12913788 [PubMed - indexed for MEDLINE]Related articles

    35.

    Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery.

    Sullivan SD, Kahn SR, Davidson BL, Borris L, Bossuyt P, Raskob G.

    Pharmacoeconomics. 2003;21(7):477-96. Review.PMID: 12696988 [PubMed - indexed for MEDLINE]Related articles

    36.

    ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.

    Vesely SK, George JN, Lämmle B, Studt JD, Alberio L, El-Harake MA, Raskob GE.

    Blood. 2003 Jul 1;102(1):60-8. Epub 2003 Mar 13.PMID: 12637323 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review.

    Mustafa BO, Rathbun SW, Whitsett TL, Raskob GE.

    Arch Intern Med. 2002 Feb 25;162(4):401-4. Review.PMID: 11863471 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.

    Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Butcher M, Brant RF, Ghali WA, Bergqvist D, Raskob GE.

    Ann Intern Med. 2001 Nov 20;135(10):858-69. Review.PMID: 11712876 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.

    Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Ghali WA, Butcher MS, Brant RF, Bergqvist D, Hamulyák K, Francis CW, Marder VJ, Raskob GE.

    Arch Intern Med. 2001 Sep 10;161(16):1952-60. Review.PMID: 11525697 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement.

    Lee A, Agnelli G, Büller H, Ginsberg J, Heit J, Rote W, Vlasuk G, Costantini L, Julian J, Comp P, van Der Meer J, Piovella F, Raskob G, Gent M.

    Circulation. 2001 Jul 3;104(1):74-8.PMID: 11435341 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Hemorrhagic complications of anticoagulant treatment.

    Levine MN, Raskob G, Landefeld S, Kearon C.

    Chest. 2001 Jan;119(1 Suppl):108S-121S. Review.PMID: 11157645 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Withholding treatment in patients with acute pulmonary embolism who have a high risk of bleeding and negative serial noninvasive leg tests.

    Stein PD, Hull RD, Raskob GE.

    Am J Med. 2000 Sep;109(4):301-6.PMID: 10996581 [PubMed - indexed for MEDLINE]Related articles

    43.

    Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists.

    Vesely S, Buchanan GR, Cohen A, Raskob G, George J.

    J Pediatr Hematol Oncol. 2000 Jan-Feb;22(1):55-61.PMID: 10695823 [PubMed - indexed for MEDLINE]Related articles

    44.

    Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility.

    Birdwell BG, Raskob GE, Whitsett TL, Durica SS, Comp PC, George JN, Tytle TL, Owen WL, McKee PA.

    Arch Intern Med. 2000 Feb 14;160(3):309-13.PMID: 10668832 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Sensitivity and specificity of helical computed tomography in the diagnosis of pulmonary embolism: a systematic review.

    Rathbun SW, Raskob GE, Whitsett TL.

    Ann Intern Med. 2000 Feb 1;132(3):227-32.PMID: 10651604 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group.

    Hull RD, Raskob GE, Brant RF, Pineo GF, Elliott G, Stein PD, Gottschalk A, Valentine KA, Mah AF.

    Arch Intern Med. 2000 Jan 24;160(2):229-36.PMID: 10647762 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    The evidence-based analysis of treatment for chronic myeloid leukemia: An introduction to its methods and clinical implications.

    George JN, Woolf SH, Raskob GE.

    Blood. 1999 Sep 1;94(5):1515-6. No abstract available. PMID: 10477675 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society.

    Tapson VF, Carroll BA, Davidson BL, Elliott CG, Fedullo PF, Hales CA, Hull RD, Hyers TM, Leeper KV Jr, Morris TA, Moser KM, Raskob GE, Shure D, Sostman HD, Taylor Thompson B.

    Am J Respir Crit Care Med. 1999 Sep;160(3):1043-66. No abstract available. PMID: 10471639 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Drug-induced thrombocytopenia.

    Rizvi MA, Shah SR, Raskob GE, George JN.

    Curr Opin Hematol. 1999 Sep;6(5):349-53. Review.PMID: 10468152 [PubMed - indexed for MEDLINE]Related articles

    50.

    Diagnosis of pulmonary embolism.

    Raskob GE, Hull RD.

    Curr Opin Hematol. 1999 Sep;6(5):280-4. Review.PMID: 10468141 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...